EV/EBITDA
43.90
-0.02-0.05%
Thu, 13 Mar 2025 23:43:26 GMT
Summary
- As of March 14, 2025, TEVA EV/EBITDA is 43.90, with a fall of -0.02 (-0.05%) during the most recent trading day.
- Over the past year, TEVA EV/EBITDA has increased by +23.14 (+111.46%).
- TEVA EV/EBITDA is now -85.11% below its all-time high of 294.78.
Performance
TEVA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TEVA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.1% | -0.0% | -0.1% |
| 1 m1 month | -0.5% | -0.4% | -0.8% |
| 3 m3 months | +91.0% | -3.6% | -0.4% |
| 6 m6 months | +126.1% | -10.8% | -10.4% |
| ytdytd | -16.2% | -16.2% | -25.7% |
| 1 y1 year | +111.5% | +3.4% | +19.8% |
| 5 y5 years | +62.4% | -3.2% | +96.1% |
TEVA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.8% | 40.83 | +7.5% | |
| 3 m | 3-month | 52.40 | -16.2% | 22.97 | +91.1% |
| 6 m | 6-month | 52.40 | -16.2% | 18.88 | +132.5% |
| 1 y | 1-year | 52.40 | -16.2% | 17.91 | +145.1% |
| 3 y | 3-year | 162.60 | -73.0% | -3793 | +101.2% |
| 5 y | 5-year | 162.60 | -73.0% | -3793 | +101.2% |
| alltime | all time | 294.78 | -85.1% | -3793 | +101.2% |
Teva Pharmaceutical Industries Limited EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 43.90(-16.2%) |
| 2024 | 52.40(+184.0%) |
| 2023 | 18.45(-152.9%) |
| 2022 | -34.89(-433.6%) |
| 2021 | 10.46(-158.6%) |
| 2020 | -17.86(-163.3%) |
| 2019 | 28.20(-89.3%) |
| 2018 | 264.65(-8119.7%) |
| 2017 | -3.30(-109.2%) |
| 2016 | 35.68(+124.1%) |
| 2015 | 15.92(+51.9%) |
| 2014 | 10.48(-25.6%) |
| 2013 | 14.08(+24.7%) |
| 2012 | 11.29(+4.2%) |
| 2011 | 10.83(-0.3%) |
| 2010 | 10.86(-41.0%) |
| 2009 | 18.41(-32.1%) |
| 2008 | 27.12(+91.7%) |
| 2007 | 14.15(+26.5%) |
| Date | Value |
|---|---|
| 2006 | 11.19(-46.7%) |
| 2005 | 20.98(+23.2%) |
| 2004 | 17.03(-6.7%) |
| 2003 | 18.25(-13.7%) |
| 2002 | 21.14(-7.2%) |
| 2001 | 22.78(-9.9%) |
| 2000 | 25.27(+33.2%) |
| 1999 | 18.97(+28.2%) |
| 1998 | 14.80(-21.2%) |
| 1997 | 18.77(-31.8%) |
| 1996 | 27.53(+0.5%) |
| 1995 | 27.39(+87.2%) |
| 1994 | 14.63(-26.7%) |
| 1993 | 19.96(-22.8%) |
| 1992 | 25.84(+91.0%) |
| 1991 | 13.53(+57.1%) |
| 1990 | 8.61(+3.9%) |
| 1989 | 8.29(-18.4%) |
| 1988 | 10.16 |
FAQ
- What is Teva Pharmaceutical Industries Limited EV/EBITDA?
- What is the all time high EV/EBITDA for Teva Pharmaceutical Industries Limited?
- What is TEVA EV/EBITDA year-to-date change?
- What is Teva Pharmaceutical Industries Limited EV/EBITDA year-on-year change?
What is Teva Pharmaceutical Industries Limited EV/EBITDA?
The current EV/EBITDA of TEVA is 43.90
What is the all time high EV/EBITDA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high EV/EBITDA is 294.78
What is TEVA EV/EBITDA year-to-date change?
Teva Pharmaceutical Industries Limited EV/EBITDA has changed by -8.50 (-16.22%) since the beginning of the year
What is Teva Pharmaceutical Industries Limited EV/EBITDA year-on-year change?
Over the past year, TEVA EV/EBITDA has changed by +23.14 (+111.46%)